IP Library Granted Patent US 9,315,781
Granted Patent B2
US 9,315,781 · App. 14/235,596 · Granted Apr 19, 2016

Infectious CDNA clone of european PRRS virus and uses thereof

Inventors: Christiane Fetzer (Tuebingen, DE); Andreas Gallei (Hannover, DE)
Assignee: Boehringer Ingelheim Vetmedica GmbH
C12N7/00A61K39/12C07K14/005A61K2039/5254A61K2039/552C12N2770/10021C12N2770/10022C12N2770/10034C12N2770/10062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,315,781
App. No.
14/235,596
Granted
Apr 19, 2016
Kind
B2
Abstract

The present invention belongs to the field of animal health and relates to a nucleic acid sequence which comprises the genome of an infectious genotype I (EU) PRRS virus clone useful for studying Porcine Reproductive and Respiratory Syndrome (PRRS), a viral disease affecting swine, and in the development of vaccines, therapeutics and diagnostics for the prophylaxis, treatment and diagnosis of PRRS.

Claims (5)

1. A plasmid or cDNA construct which encodes a genotype I PRRS virus and which is capable of producing infectious virus when transfected into cells, and comprises a cDNA sequence having at least 94% sequence identity over the full length of the cDNA sequence of SEQ ID NO:1.

2. The plasmid or cDNA construct of claim 1 , wherein said molecule comprises a cDNA sequence having at least 95% sequence identity with the cDNA sequence of SEQ ID NO:1.

3. A genotype I PRRS virus whose genome comprises a plasmid or cDNA construct according to claim 1 or whose genome comprises an RNA molecule encoded by cDNA sequence according to claim 1 .

4. A method for producing a genotype I PRRS virus comprising transfecting a cell with the DNA construct of claim 3 .

5. A composition comprising a plasmid or cDNA construct of claim 1 suspended in a suitable amount of a pharmaceutically acceptable diluent or excipient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2014
From: FETZER, CHRISTIAN; GALLEI, ANDREAS
To: BOEHRINGER INGELHEIM VETMEDICA GMBH
Reel/Frame 032486/0241 →
Priority Claims (2)
EP 11176019 · Jul 29, 2011 · regional
EP 11176023 · Jul 29, 2011 · regional
Continuity (1)
Related Publication 20140314808A1 · Oct 23, 2014